[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$97share Graphic](https://lunarcrush.com/gi/w:26/t:$97share.png) $97share

Community support is strong, but market volatility is a concern. Keep an eye on the price action.

### About $97share
A social media community.  

### Insights [#](/topic/$97share/insights)
- $97share engagements is up XXXXXX% from the previous week.

### Engagements: XXX [#](/topic/$97share/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$97share/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$97share/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Week**: XXXXXX +218%  
**1 Month**: XXXXX +215%  
**1-Year High**: XXXXX on 2025-09-29  
**1-Year Low**: X on 2025-08-31  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: X [#](/topic/$97share/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$97share/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$97share/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Month**: X +600%  
**1-Year High**: XX on 2025-09-29  
**1-Year Low**: X on 2025-08-07  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$97share/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$97share/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$97share/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $97share in the last XX hours which is down XX% from X in the previous XX hours
**Daily Average**: X  
**1 Month**: X +500%  
**1-Year High**: XX on 2025-09-29  
**1-Year Low**: X on 2025-08-07  

The most influential creators that mention $97share in the last XX hours

| Creator                                    | Rank | Followers | Posts | Engagements |
| -------                                    | ---- | --------- | ----- | ----------- |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ) | X    | XXXXXX    | X     | XXX         |

[View More](/list/creators/$97share/100)

**Top assets mentioned**
In the posts about $97share in the last XX hours

[Merus N.V. Common Shares (MRUS)](/topic/$mrus)
[Akero Therapeutics, Inc. Common Stock (AKRO)](/topic/akro-akero-therapeutics-inc)

**Top topics mentioned**
In the posts about $97share in the last XX hours

[$8b](/topic/$8b), [$gmab](/topic/$gmab), [$mrus](/topic/$mrus), [$gmabco](/topic/$gmabco), [acquisition](/topic/acquisition), [$psnl](/topic/$psnl), [$dwtx](/topic/$dwtx), [investment](/topic/investment), [akro akero therapeutics inc](/topic/akro-akero-therapeutics-inc), [$novcde](/topic/$novcde), [$52b](/topic/$52b), [$54share](/topic/$54share), [$6share](/topic/$6share)

### Top Social Posts [#](/topic/$97share/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"📢M&A News: Novo Nordisk to acquire Akero Therapeutics for up to $5.2B 🚨 💰 $54/share cash + $6/share CVR tied to FDA approval of efruxifermin for MASH cirrhosis 📈 XX% premium to Akeros pre-deal price 🧬 Adds Phase X FGF21 analog EFX to Novos metabolic portfolio 🗓 Deal closes by YE 2025 pending approvals 🤔 Signals renewed M&A momentum in MASH/NASH. Validates FGF21 pathway.potential re-rating for peers like $VKTX $TERN See image for more details"  
[X Link](https://x.com/BiopharmIQ/status/1976303356961550704) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-09T15:06Z 27.4K followers, 16K engagements


"🔥 $GMAB soars X% after announcing $8B acquisition of Merus. Deal includes $97/share cash offer for Netherlands-based biotech firm. Analysts bullish: Truist maintains Buy rating ($46 PT) TD Cowen raises PT to $XX from $XX. Acquisition expected to close Q1 2026. @grok"  
[X Link](https://x.com/CryptoMilox/status/1973113259797442681) [@CryptoMilox](/creator/x/CryptoMilox) 2025-09-30T19:50Z 1075 followers, XXX engagements


"📢 M&A News: Genmab $GMAB to acquire Merus $MRUS for $8B 💰 $97/share all-cash (41% premium $8B EV) 🧬 Adds Phase X bispecific petosemtamab (BTD in head & neck cancer) Ph2 data showed strong ORR & PFS SOC; Ph3 readouts in 2026 Expected launch 2027 $1B sales by 2029 multi-billion potential longer term 🗓 Closing by Q1 2026 See photo for more info 👇"  
[X Link](https://x.com/BiopharmIQ/status/1972672796154355942) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-09-29T14:40Z 27.4K followers, 10.4K engagements


"Biotech Movers & News 🧬🚀 🔹 $DWTX Dogwood Therapeutics acquires global rights to Serpin Pharmas SP16 (7.31% equity). NCI-funded Phase 1b in CIPN starts 1H26. Synergistic with Halneuron (Phase 2b interim data Dec 2025). 🔹 $GMAB Genmab to buy Merus ($MRUS) for $8B cash ($97/share) adding Phase X petosemtamab. Boosts late-stage oncology pipeline & 2027 launches. 🔹 $RDHL RedHill wins $10M appellate judgment vs. Kukbo + Korean court asset seizure order"  
[X Link](https://x.com/AnunTrades/status/1972654562386571711) [@AnunTrades](/creator/x/AnunTrades) 2025-09-29T13:27Z 6712 followers, XXX engagements